| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/09/2021 | Clarus Therapeutics Holdings, Inc. | | Grant | Common Stock | 2.7M | $0.00 | $0 | See Footnote | 09/09/2021 |
| 09/09/2021 | Clarus Therapeutics Holdings, Inc. | | Grant | Common Stock | 2.5M | $0.00 | $0 | See Footnote | 09/09/2021 |
| 09/09/2021 | Clarus Therapeutics Holdings, Inc. | | Grant | Common Stock | 490.5k | $0.00 | $0 | See Footnote | 09/09/2021 |
| 10/09/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Exercise | Common Stock Warrent | 60.2k | $3.88 | $233.3k | see footnote | 10/09/2014 |
| 10/09/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Disposition | Common Stock | 9.8k | $23.89 | $233.4k | see footnote | 10/09/2014 |
| 05/14/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Exercise (in-the-money or at-the-money) | Common Stock Warrants | 65.8k | $3.88 | $255.4k | see footnote | 05/14/2014 |
| 05/14/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Sale | Common Stock | 12.4k | $20.60 | $255.4k | see footnote | 05/14/2014 |
| 05/14/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Exercise | Common Stock Warrants | 65.8k | $3.88 | $255.4k | see footnote | 05/14/2014 |
| 05/14/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Disposition | Common Stock | 12.4k | $20.60 | $255.4k | see footnote | 05/14/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 90.2k | $3.88 | $350k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Preferred Stock Warrant | 406k | $0.86 | $350k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 169.6k | $3.88 | $658k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Preferred Stock Warrant | 763.3k | $0.86 | $658k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 59.3k | $3.88 | $229.9k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Preferred Stock Warrant | 266.8k | $0.86 | $229.9k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 60.2k | $3.88 | $233.3k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Preferred Stock Warrant | 270.7k | $0.86 | $233.3k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 65.8k | $3.88 | $255.4k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Preferred Stock Warrant | 296.3k | $0.86 | $255.4k | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Series E Convertible Preferred Stock | 1.1M | $0.00 | $0 | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Series D Convertible Preferred Stock | 11.9M | $0.00 | $0 | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Series C Convertible Preferred Stock | 7.6M | $0.00 | $0 | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Series B Convertible Preferred Stock | 2.3M | $0.00 | $0 | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Purchase | Common Stock | 83.3k | $12.00 | $1M | See footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock | 5.1M | $0.00 | $0 | See footnote | 02/10/2014 |